Skip to main content

Advertisement

Log in

Stroke

Is thrombolysis safe in anticoagulated ischaemic stroke?

  • News & Views
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

Intracerebral haemorrhage is the most serious complication of intravenous thrombolysis in ischaemic stroke, and whether thrombolysis can be performed in patients receiving anticoagulants is an unresolved issue. Data from a large European registry now confirms that thrombolysis in some patients receiving warfarin is as safe as in non-anticoagulated patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Adams, H. P. et al. Guidelines for the Early Management of Adults with Ischemic Stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 38, 1655–1711 (2007).

    Article  PubMed  Google Scholar 

  2. European Stroke Organisation (ESO) Executive Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis. 25, 457–507 (2008).

  3. Mazya, M. V. et al. Safety of IV thrombolysis for ischemic stroke in patients treated with warfarin. Ann. Neurol. http://doi.dx.org/10.1002/ana.23924.

  4. Xiang, Y. et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA 307, 2600–2608 (2012).

    Google Scholar 

  5. Diener, H. C. et al. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment. Lancet Neurol. 12, 677–688 (2013).

    Article  CAS  PubMed  Google Scholar 

  6. Frank, B. et al. Thrombolysis in stroke despite contraindications or warnings? Stroke 44, 727–733 (2013).

    Article  CAS  PubMed  Google Scholar 

  7. Rizos, T. et al. Oral anticoagulants—a frequent challenge for the emergency management of acute ischemic stroke. Cerebrovasc. Dis. 34, 411–418 (2012).

    Article  CAS  PubMed  Google Scholar 

  8. Gladstone. et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 40, 235–240 (2009).

    Article  CAS  PubMed  Google Scholar 

  9. Rizos, T. et al. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants. Stroke 40, 3547–3551 (2009).

    Article  CAS  PubMed  Google Scholar 

  10. Sun, L., Zhou, W., Ploen, R., Zorn, M. & Veltkamp, R. Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia. Thromb. Haemost. 110, 153–161 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roland Veltkamp.

Ethics declarations

Competing interests

R. Veltkamp has received consulting fees from Boehringer Ingelheim, Bayer, BMS/Pfizer and Roche; research support from Bayer and Boehringer Ingelheim; and speaker's honoraria from Bayer, Boehringer Ingelheim, BMS/Pfizer, Roche, Apoplex Medical Technologies and CSL Behring. T. Rizos declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Veltkamp, R., Rizos, T. Is thrombolysis safe in anticoagulated ischaemic stroke?. Nat Rev Neurol 9, 492–493 (2013). https://doi.org/10.1038/nrneurol.2013.159

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2013.159

  • Springer Nature Limited

Navigation